The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.30
Bid: 4.10
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.40 (9.756%)
Open: 4.30
High: 4.30
Low: 4.30
Prev. Close: 4.30
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Data Access Licence and Royalty Agreement

13 Jan 2014 07:00

RNS Number : 4441X
Eden Research plc
13 January 2014
 



 

Eden Research Plc

("Eden" or "Company")

 

Data Access Licence and Royalty Agreement

 

Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that it has granted access to its EU regulatory data and dossiers to Desarrollo Agricola y Minero S.A. ("Daymsa") of Zaragoza, Spain.

 

In 2013, Eden received approval for three active substances under the European Union Regulation ("EC") No. 1107/2009 concerning the Placing of Plant Protection Products on the Market. This data, which was generated by Eden to register its own plant protection product 3AEY, is also of value to third parties as a basis to register their own products using one or more of the same active substances.

 

Daymsa already uses similar natural ingredients in its existing product portfolio and shall now register new products using the data for the active substances registered by Eden.

 

Clive Newitt, Managing Director of Eden comments: "Having invested a considerable amount of time, money and effort into the EU approvals of the three active substances, it is pleasing to see a return on our investment through upfront and milestone payments, as well as royalties on commercial sales. Daymsa is a well-established business with presence in Europe and Latin America and so the potential reach of these new products is significant."

 

Juan Pardos, General Manager of Daymsa comments: "Daymsa, a leading producer in Europe of Leonardite, is a 34 year old Spanish company that specialized in "Bio-stimulant and Bio-control products" even before those terms became of general use in ecological and conventional agriculture. This strategic agreement with Eden will enable us to become a leading company in Europe not only as leading producer of Leonardite but also a leading producer of "Vegetable Extract based" Bio-Control products."

 

Enquiries:

 

Eden Research plc

www.edenresearch.com

Clive Newitt, Managing Director

Tel: 01993 862 761

Alex Abrey, Chief Financial Officer

W H Ireland Limited

Tel: 0117 945 3471

John Wakefield

Walbrook PR Ltd

Tel: 020 7933 8780 or eden@walbrookpr.com

Paul McManus (Media Relations)

Mob: 07980 541 893

Paul Cornelius (Investor Relations)

Mob: 07827 879 496

 

 

 

 

Notes:

 

Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

 

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

 

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

 

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

 

The Company has a number of patents and has a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, identifying suitable industrial partners and entering into licence agreements.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

 

For more information about Eden, please visit www.edenresearch.com

  

 

 

 

 

Daymsa, Europe´s leading producer of Leonardite started producing Leonardite based soil amendment products as early as in 1979. Since that time our investment in Quality and Sustainable Agriculture has been strengthened with the development of a full range of Bio-stimulant and Bio-control Products.

 

The increase in the world's population, a higher percentage of the world population entering the consumer market and the harsh competition of the Bio-Fuels over the limited land resources compelled Bio-technological companies like Daymsa to force their Research and Development departments into the search for solutions that can help to increase the world production of food, maintaining and increasing the long term quality and richness of the land.

 

The Sustainable Agriculture Solutions of Daymsa include a full range of

a) Soil and water conditioners

b) Bio-stimulants

c) Bio-control Products

d) Specialized microelement deficiency amendments

 

The actual Biocontrol portfolio products of Daymsa is based on the broad experience of Daymsa and its three subsidiary companies established in Brazil, Colombia and Ecuador not only in the European and Southern American market but also in the Middle East and North American countries. The Strategical Agreement signed with Eden will allow Daymsa to become one of the first producer of very effective Plant Protection Products based on Plant Extracts Registered in Europe.

 

For more information about Daymsa, please visit www.daymsa.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRGGUPCGUPCGQP
Date   Source Headline
9th May 20247:00 amRNSInvestor Presentation via Investor Meet Company
7th May 20247:01 amRNSAppointment of Non-Executive Director
7th May 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
31st Jan 20247:00 amRNSBoard Change
22nd Jan 20247:00 amRNSTrading Update
19th Jan 20243:00 pmRNSHolding(s) in Company
9th Jan 20247:01 amRNSMevalone Approval in the State of California
18th Dec 20237:00 amRNSEcovelexâ„¢2023 Approval in Italy
28th Nov 20237:00 amRNSSmall Cap Virtual Investor Conference
1st Nov 20237:00 amRNSChange of Nominated Adviser and Broker
9th Oct 20234:44 pmRNSHolding(s) in Company
9th Oct 20234:39 pmRNSHolding(s) in Company
9th Oct 202312:46 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSCompletion of Conditional Placing
29th Sep 20237:01 amRNSHalf Yearly Report
29th Sep 20237:00 amRNSCapital Raising Update
31st Aug 20236:25 pmRNSGrant of Awards under Long-Term Incentive Plan
17th Aug 20239:27 amRNSResult of GM and Capital Raising update
16th Aug 20237:00 amRNSFirst Order For Ecovelex
2nd Aug 20233:22 pmRNSResult of Retail Offer
28th Jul 20235:00 pmRNSRetail Offer
28th Jul 20235:00 pmRNSPlacing and Retail Offer
3rd Jul 20237:00 amRNSRegulatory Application for Ecovelex in the UK
30th Jun 20239:17 amRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSAppointment of New Product Distributor – Colombia
9th Jun 20234:29 pmRNSHolding(s) in Company
7th Jun 20237:00 amRNSPublication of Annual Report and Notice of AGM
5th Jun 20234:47 pmRNSHolding(s) in Company
30th May 20237:00 amRNSEden and Corteva seek to bring Ecovelex to market
17th May 20237:00 amRNSExercise of Options
15th May 20237:00 amRNSMevalone authorisation in New Zealand
12th May 20237:00 amRNSRegulatory approvals in California and Florida
5th May 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
17th Apr 20237:00 amRNSRegulatory authorisation for Mevalone in Poland
23rd Mar 20237:00 amRNSUS State Regulatory Approvals Update
30th Jan 20237:00 amRNSFirst Mevalone authorisation for domestic use
10th Jan 20237:00 amRNSTrading Update
15th Dec 20222:01 pmEQSEden Research signs new Mevalone distribution deal
15th Dec 20227:00 amRNSDistribution Agreement for Mevalone in France
30th Nov 20227:00 amRNSOrganic Certification in Greece
24th Oct 202212:00 pmRNSAIM Rule 17 Notification
3rd Oct 20224:39 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSEden Half Yearly Report
28th Sep 20228:46 amRNSAppointment of Auditor
27th Sep 20225:08 pmEQSEden granted US EPA regulatory approval
26th Sep 20227:00 amRNSEden granted US EPA regulatory approval
2nd Sep 20227:00 amRNSAppointment of Non-Executive Director
22nd Aug 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.